Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Papatheodoridis, George; Sypsa, Vana; Dalekos, George; Yurdaydin, Cihan; van Boemmel, Florian; Buti, Maria; Goulis, John; Calleja, Jose; Chi, Heng; Manolakopoulos, Spilios; Loglio, Alessandro; Siakavellas, Spyros; Gatselis, Nikolaos; KESKİN, ONUR; Lehretz, Maria; Savvidou, Savvoula; de la Revilla, Juan; Hansen, Bettina; Kourikou, Anastasia; Vlachogiannakos, Ioannis; Galanis, Kostantinos; İDİLMAN, RAMAZAN; Colombo, Massimo; Esteban, Rafael; Janssen, Harry; Berg, Thomas; Lampertico, Pietro

doi:10.1016/j.jhep.2018.01.031

Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Atıf İçin Kopyala

Papatheodoridis G. V., Sypsa V., Dalekos G., Yurdaydin C., van Boemmel F., Buti M., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.68, sa.6, ss.1129-1136, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 68 Sayı: 6
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.jhep.2018.01.031
Dergi Adı: JOURNAL OF HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1129-1136
Hacettepe Üniversitesi Adresli: Evet

Özet

Background & Aims: The effects of long-term antiviral therapy on survival have not been adequately assessed in chronic hepatitis B (CHB). In this 10-centre, ongoing cohort study, we evaluated the probability of survival and factors affecting survival in Caucasian CHB patients who received long-term entecavir/tenofovir therapy.